Another tail kicking

2,187 Views | 9 Replies | Last: 3 yr ago by Oldbear83
CTbruin
How long do you want to ignore this user?
We are down 10-3 in the 5th at Texas State

Their fans are laughing at us
GShack
How long do you want to ignore this user?
1 possession game with plenty of time.
Oldbear83
How long do you want to ignore this user?
GShack said:

1 possession game with plenty of time.
Our football team would definitely win.

But we have a baseball team only in theory and uniform.
That which does not kill me, will try again and get nastier
Stefano DiMera
How long do you want to ignore this user?
I mean...they are #19 in country
Oldbear83
How long do you want to ignore this user?
Stefano DiMera said:

I mean...they are #19 in country
And judging by our play, we're around #81
That which does not kill me, will try again and get nastier
BellCountyBear
How long do you want to ignore this user?
Oldbear83 said:

GShack said:

1 possession game with plenty of time.
Our football team would definitely win.

But we have a baseball team only in theory and uniform.
Our football team barely beat them last year.
Jack Bauer
How long do you want to ignore this user?
143 days until kickoff...
IowaBear
How long do you want to ignore this user?
81 seems generous, more like 181st
GShack
How long do you want to ignore this user?
Warren Nolan has our RPI at #54. SOS is #8.

https://www.warrennolan.com/baseball/2022/rpi-live
Oldbear83
How long do you want to ignore this user?
GShack said:

Warren Nolan has our RPI at #54. SOS is #8.

https://www.warrennolan.com/baseball/2022/rpi-live
I see lots of losing teams with strong SOS. Does not matter if you can't win.

As for RPI, that's on metric and we know historically that at-large teams need to be in the top 35, ideally in the top 30.

The stated goal was a regional. We're not playing like an NCAA Tournament team, plain and ugly.
That which does not kill me, will try again and get nastier
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.